Artículo
Development and in vitro evaluation of gastroretentive floating tablets of metformin
Romero Guerra, D.; Esquivel Ferriño, P.; González Barranco, P.; Cantú Cárdenas, L.; Orozco Beltrán, E.; Longhi, Marcela Raquel
; Gracia Vásquez, S.
Fecha de publicación:
02/2017
Editorial:
Colegio de Farmacéuticos de la Provincia de Buenos Aires
Revista:
Acta Farmacéutica Bonaerense
ISSN:
0326-2383
e-ISSN:
2362-3853
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
The objective was to evaluate the in vitro effect of hydrophilic polymers: hydroxypropylmethyl cellulose (HPMC); HPMC K4M, HPMC K15M, carbopol and xanthan gum in the formulation of a gastroretentive floating extended-release system of metformin. Compatibility between metformin and excipients was determined by using infrared spectroscopy. Tablets were obtained through wet granulation method and they were evaluated through pharmacothechnical and pharmacopeial tests. Short term stability studies and a comparison between selected formulation and the brand currently marketed were carried out. Prepared tablets with combination of xanthan gum and HPMC K15M showed a successful behavior having a floating lag time of 65 s, a total floating time higher at 13 h and a 94% of released drug at 13 h. The presence of polymers significantly impacted the release rate for metformin. Such behavior represented an advantage in comparison with metformin extended-release tablets currently marketed in Mexico.
Palabras clave:
Extended-Release
,
Gastroretentive
,
Metformin Hydrochloride
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(UNITEFA)
Articulos de UNIDAD DE INVESTIGACION Y DESARROLLO EN TECNOLOGIA FARMACEUTICA
Articulos de UNIDAD DE INVESTIGACION Y DESARROLLO EN TECNOLOGIA FARMACEUTICA
Citación
Romero Guerra, D.; Esquivel Ferriño, P.; González Barranco, P.; Cantú Cárdenas, L.; Orozco Beltrán, E.; et al.; Development and in vitro evaluation of gastroretentive floating tablets of metformin; Colegio de Farmacéuticos de la Provincia de Buenos Aires; Acta Farmacéutica Bonaerense; 36; 5; 2-2017; 939-945
Compartir